Our unit studies how immune cells are organized and programmed within tissues during chronic inflammation, with a primary focus on tuberculosis (TB) and granuloma biology. TB granulomas are highly structured immune environments that simultaneously contain infection and enable bacterial persistence. Our work seeks to understand the cellular interactions and microenvironmental cues that govern these opposing outcomes. To do this, we integrate cutting-edge spatial mapping and multiplexed imaging approaches to resolve tissue architecture at single-cell resolution. These technologies allow us to define where specific immune and stromal populations reside, how they interact, and how their functional states are shaped by the local environment. We are particularly interested in how spatial context influences immune cell behavior in ways that cannot be captured by dissociated or bulk analyses. Complementing our work in human tissues, we develop and apply human-based organoid systems that model key features of granuloma formation and immune activation in vitro. These platforms enable controlled perturbation of host and pathogen factors, allowing us to dissect mechanisms of immune organization and function with high precision. A central theme of our research is immunometabolism. We seek to understand how metabolic constraints and adaptations within the granuloma microenvironment influence immune cell function and fate. We investigate how nutrient availability, hypoxia, and metabolic signaling pathways shape immune responses and contribute to either pathogen control or disease progression. Ultimately, our goal is to translate these insights into host-directed therapeutic strategies for TB and other granulomatous diseases. By identifying the principles that govern effective versus dysfunctional immune organization, we aim to inform new approaches that reprogram tissue immunity to improve disease outcomes.
Spatial Immunology Unit, Spring 2026
Left to right: Sharmila Talukdar, Sarah Douglas, Erin McCaffrey, Ingrid Smith
Erin F. McCaffrey, Ph.D.
Independent Research Scholar
Education:
B.S., Microbiology, 2016, University of Maryland, College Park, Maryland
Ph.D., Immunology, 2022, Stanford University, California
Erin McCaffrey began her academic training at the University of Maryland, College Park, where she earned a B.S. in Microbiology in 2016. During this time, she conducted research with Dr. Rohan Fernandes at the Children’s National Medical Center Sheikh Zayed Institute, developing a tumor-targeting biohybrid system composed of Prussian Blue nanoparticles and attenuated Salmonella typhimurium. She...
Sarah M. Douglas, B.A.
NIH-OxCam DPhil Student
Education:
B.A., Molecular, Cellular and Developmental Biology, 2023, University of Colorado, Colorado
Languages Spoken: Japanese, French
Sarah is a graduate student in the NIH-OxCam program co-advised by Dr. Adrien Hallou at the University of Oxford. She utilizes high-dimensional imaging, spatial transcriptomics, and computational biology to study the immunometabolism and mechanobiology of tuberculosis granulomas.
Ingrid A. Smith, B.S.
Postbac IRTA
Education:
B.S., Biology, 2025, Emory University, Georgia
Ingrid focuses on the metabolic environment of tuberculosis granulomas with in vitro experiments and transcriptomic data from the lab’s 3D assembloid and immunovascular organoid systems. She is working on screening metabolic modifiers intended to identify pathways important for host control of infection.
Sharmila Talukdar, Ph.D.
Postdoctoral Fellow
Education:
Ph.D., 2023, CSIR-Institute of Microbial Technology, Chandigarh, India
M.Sc., 2016, Tezpur University, Assam, India
B.Sc., 2014, Cotton College, Assam, India
Languages Spoken: Hindi, Assamese, Bengali
Sharmila’s research focuses on characterizing the metabolic and immune markers that define granuloma and cavity formation in a marmoset model of tuberculosis (TB). She is also investigating the cellular and molecular mechanisms underlying TB granuloma formation using a 3D assembloid model system.
Former Research Group Members
Evan DuVivier